Biotech Breakthrough Stuns Doctors

For your weekly reading, we bring you the week's most popular stories from Wealth Daily and our sister site, Energy and Capital... For your weekly reading, we bring you the week's most popular stories from Wealth Daily and our sister site, Energy and Capital. [Wealth Daily logo] Biotech Breakthrough Stuns Doctors [Briton Ryle Photo] By [Briton Ryle]( Written Jan 06, 2021 For your weekly reading, we bring you the week's most popular stories from [Wealth Daily]( and our sister site, [Energy and Capital](... [2020 Was a Big Year for SPACs](Special purpose acquisition companies (SPACs) have raised over $70 billion in IPO proceeds in the U.S. in 2020. It’s been a record-breaking year for SPACs, which have become an alternative way for some companies to make their public debut. Can we expect this trend to continue into 2021? [This Cold-Storage Stock Is Heating up Fast](Normally on Wednesdays, Keith Kohl brings you his latest market insights. But over the last few weeks, while he hunted down your next round of opportunities for 2021, editor Sean McCloskey has filled in. Today, he shares a COVID-19 play that no one is talking about but could offer you impressive upside. [Biotech Breakthrough Stuns Doctors](Molecule 520 is about to turn the treatment of the world’s toughest chronic diseases on its head. That’s why the FDA has already given it breakthrough status, cutting all the red tape standing in the way of going to market. Put down a small $1,000 stake now, and you could walk away with a fortune. [An 8% Dividend... Paid Monthly? Yes, but You Need To Move Quickly]( One of my favorite income plays right now is an under-the-radar fund that pays an incredible 8% monthly dividend. I'm so excited about this fund that I've made it a core holding in my "9% Monthly Payer" portfolio — an easy-to-buy collection of stocks and funds that could hand you $3,750+ in dividend payouts every single month! All the details are waiting for you in this exclusive briefing. [Slack Starts 2021 With a Global Outage](Slack (NYSE: WORK) started off the new year at a low point. For most people, it was the first day back to work after the holiday and they couldn’t even log into Slack to start their first workday of 2021. Early Monday morning, Slack reported that a global outage was having a significant impact on its platform. [Nailed It (Almost): 2020 Market Predictions Recap](It’s that time of the year when we stock market pontificators write about what we expect in the new year. But first, let's see how we did with last year's estimates. It turns out that even with the monkey wrench COVID-19 threw at us, we did pretty well. [Trump’s Last Executive Order](Trump is flexing his executive muscle in a final push to defend America’s borders. But that’s not all. Trump’s urgent directive is also creating the biggest investing opportunity I’ve ever found. The moment this emergency order takes effect, three companies will skyrocket. [Predictions 2021](It’s an end-of-year tradition here at Angel Publishing to dust off the ol’ crystal ball and offer up some predictions for the coming year. [Investing in the Shroom Boom With These Psychedelic Mushroom Stocks](It’s hard to believe that we went from an all-out prohibition on psychedelics back in the 1970s to a rush to get the FDA to approve new psychedelic treatments for mental illness. But that’s exactly where we are, and no investor in his right mind would ignore this opportunity. [Urgent Notice About Your Account Upgrade]( You’ve become eligible for a special membership upgrade that is not available to the general public. Believe me when I say that this upgrade is unlike anything else we offer, and I’m willing to bet that it could hand you more wealth than you ever thought possible. View your private invitation now. Until next time, [brit''s sig] Briton Ryle [[follow basic]@BritonRyle on Twitter]( A 21-year veteran of the newsletter business, Briton Ryle is the editor of [The Wealth Advisory]( income stock newsletter, with a focus on top-quality dividend growth stocks and REITs. Briton also manages the [Real Income Trader]( advisory service, where his readers take regular cash payouts using a low-risk covered call option strategy. He also contributes a weekly column to the [Wealth Daily]( e-letter. To learn more about Briton, [click here.]( Browse Our Archives [Slack Starts 2021 With a Global Outage]( [Predictions 2021]( [How Bad Sci-Fi Became Tomorrow's Christmas Stocking Stuffer]( [Upstart Soars 47% on Market Debut]( [The Bubble Will Burst and the Frauds Will Be Exposed]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2021, [Angel Publishing LLC](. All rights reserved. 3 E Read Street Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.